BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Field Safety Notice for Atellica IM Erythropoietin (EPO) Assay; ADVIA Centaur Erythropoietin (EPO) Assay; by Siemens Healthcare Diagnostics Inc. Tarrytown

2024.02.29

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 02807/24

For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.

Urgent Field Safety Notice for Atellica IM Erythropoietin (EPO) Assay; ADVIA Centaur Erythropoietin (EPO) Assay; by Siemens Healthcare Diagnostics Inc. Tarrytown , Download_VeroeffentlichtAm_EN PDF, 257KB, File does not meet accessibility standards